The December issue of Surgery traditionally publishes manuscripts presented at the Annual Meeting of the American Association
of Endocrine Surgeons. This is one of the best sources of information for endocrine
diseases, including nuances in the management of thyroid cancer. In recent years,
there has been a paradigm shift in the management issues in thyroid cancer and new
issues have been raised with technological advances in evaluating the extent of the
disease, both pre-operatively and postoperatively. Our debate used to focus on extent
of thyroidectomy in well-differentiated thyroid cancer, namely, total versus less
than total thyroidectomy. The contemporary controversial issue mainly centers on the
management of neck nodes, both central compartment (level VI) and lateral neck nodes.
The American Thyroid Association (ATA) guidelines published in 2006 recommended that
central compartment dissection should be considered for papillary carcinoma of the
thyroid.
1
Since these guidelines were published, there has been considerable debate in relation
to the central compartment. Strong sentiments have been expressed by various authors.
2
,
3
,
4
,
5
I do not think the ATA guidelines committee realized the controversy that would be
generated by this statement. What was not appreciated was the risk group definition
as an indication for evaluation and gross findings of the central compartment during
surgery. The recent revised guidelines, which are expected to be published soon, revisit
the issue of prophylactic central compartment dissection. The management of neck nodes
and elective nodal dissection at level VI has generated several prospective studies
and debates, primarily based on the philosophy of the individual surgeon rather than
showing any major outcome advantages. There are 3 excellent papers addressing the
issue of central compartment lymph nodes published in this issue of Surgery.To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to SurgeryAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- American Thyroid Association Guidelines Taskforce. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer.Thyroid. 2006; 16: 109-142
- Central lymph node dissection in differentiated thyroid cancer.World J Surg. 2007; 31: 895-904
- Routine level VI lymph node dissection for papillary thyroid cancer: surgical technique.Aust N Z J Surg. 2007; 77: 203-208
- Routine ipsilateral level VI lymphadenectomy reduces postoperative thyroglobulin levels in papillary thyroid cancer.Surgery. 2006; 140: 1000-1007
- The pros and cons of prophylactic central compartment lymph node dissection for papillary thyroid carcinoma.Thyroid. 2009; 19: 683-689
- Routine pre-operative ultrasound for papillary thyroid cancer: effects on cervical recurrence.Surgery. 2009; 146: 1063-1072
- Role of pre-operative ultrasonography in the surgical management of patients with thyroid cancer.Surgery. 2003; 134: 946-954
- Does failure to perform prophylactic level VI node dissection leave persistent disease detectable by ultrasonography in patients with low-risk papillary carcinoma of the thyroid?.Surgery. 2009; 146: 1182-1187
- The long term outcome of papillary thyroid carcinoma patients without primary central lymph node dissection: expected improvement of routine dissection.Surgery. 2009; 146: 1188-1195
Article info
Publication history
Accepted:
October 5,
2009
Identification
Copyright
© 2009 Mosby, Inc. Published by Elsevier Inc. All rights reserved.